Search results
Geron surges after winning first US FDA approval for blood disorder drug
Reuters via Yahoo News· 6 days ago(Reuters) -Shares of Geron surged more than 20% on Friday, a day after the company gained its first...
Smart Money Is Betting Big In BMY Options - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 6 days agoLoading... Loading... Investors with a lot of money to spend have taken a bullish stance on Bristol-Myers Squibb BMY . And retail traders should know. We noticed this today when the trades showed ...
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
Benzinga via AOL· 6 days agoOn Thursday, the FDA approved Geron Corporation's (NASDAQ:GERN) Rytelo (imetelstat) for adult...
NJ health care, pharmaceutical companies cutting jobs as tech disrupts industry
The Bergen Record via Yahoo News· 6 days agoSome of the largest pharmaceutical and health care companies in New Jersey are cutting their head...
Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
Zacks· 6 days agoFree Report) . Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important ...
Avidity drug for muscular dystrophy shows promise; Syntis takes new approach to weight loss
BioPharma Dive via Yahoo Finance· 1 day agoStudy results indicated Avidity’s medicine muted target genes. Elsewhere, Syntis revealed obesity...
Geron Stock Soars on FDA Approval of Drug for Patients With Rare Blood Cancers
Investopedia· 6 days agoGeron (GERN) shares skyrocketed over 19% in intraday trading Friday after the Food and Drug...
Geron surges after winning first US FDA approval for blood disorder drug
Reuters· 6 days ago, opens new tab surged more than 30% on Friday, a day after the company gained its first approval...
Radiopharmaceuticals Are A Buzzy Area For Deal-Making
Crunchbase· 5 hours agoWhen reporting on startup investment, big funding rounds and M&A deals for pharmaceutical companies...
Geron shares surge after U.S. FDA approves blood disorder drug
WSAU Wausau· 6 days ago(Reuters) - Shares of Geron rose almost 16% on Friday before market, a day after getting its first...